Company news

Evofem Biosciences, Inc. news in 2022

Evofem Biosciences, Inc.'s news releases, calls and decks from 2022, newest first.

View company

OTC Markets Group Grants Evofem Additional Time to File Quarterly Report on Form 10-Q for the Quarter Ended September 30, 2022

December 29, 2022

Evofem Reports Top-Line Results from Phase 3 EVOGUARD Clinical Trial Evaluating EVO100 for Prevention of Chlamydia and Gonorrhea Infection in Women

October 11, 2022

OTC Markets Group Welcomes New OTCQB Companies – October 10

October 10, 2022

Evofem Biosciences Announces Approval of Phexxi in Nigeria

October 6, 2022

Evofem Biosciences Announces Uplisting to OTCQB

October 3, 2022

Calls in 2022

Decks in 2022